FDA says Covid vaccines that target new variants won’t need large clinical trials to win approval

Posted by on February 22, 2021 2:12 pm
Categories: US National Stories

The FDA said Monday that modified Covid-19 vaccines against new, emerging variants may be authorized without the need for lengthy clinical trials.

Leave a Reply

Your email address will not be published.